Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

N. Lawrence; A. Martin; G. Toner; M. Stockler; L. Buizen; D. Thomson; V. Gebski; M. Friedlander; A. Yeung; N. Wong; H. Gurney; M. Rosenthal; N. Singhal; G. Kichenadasse; S. Wong; C. Lewis; P. Vasey; P. Grimison

doi:10.1093/annonc/mdw313

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

N. Lawrence, A. Martin, G. Toner, M. Stockler, L. Buizen, D. Thomson, V. Gebski, M. Friedlander, A. Yeung, N. Wong, H. Gurney, M. Rosenthal, N. Singhal, G. Kichenadasse, S. Wong, C. Lewis, P. Vasey, P. Grimison

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	2302-2303
Number of pages	2
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	27
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdw313
Publication status	Published - 1 Dec 2016
Externally published	Yes

Access to Document

10.1093/annonc/mdw313

Link to publication in Scopus

Cite this

Lawrence, N., Martin, A., Toner, G., Stockler, M., Buizen, L., Thomson, D., Gebski, V., Friedlander, M., Yeung, A., Wong, N., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S., Lewis, C., Vasey, P., & Grimison, P. (2016). Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Annals of oncology : official journal of the European Society for Medical Oncology, 27(12), 2302-2303. https://doi.org/10.1093/annonc/mdw313

Lawrence, N. ; Martin, A. ; Toner, G. ; Stockler, M. ; Buizen, L. ; Thomson, D. ; Gebski, V. ; Friedlander, M. ; Yeung, A. ; Wong, N. ; Gurney, H. ; Rosenthal, M. ; Singhal, N. ; Kichenadasse, G. ; Wong, S. ; Lewis, C. ; Vasey, P. ; Grimison, P. / Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours : updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). In: Annals of oncology : official journal of the European Society for Medical Oncology. 2016 ; Vol. 27, No. 12. pp. 2302-2303.

@article{43f9e0590d3d4c62a83ba6c32f48118e,

title = "Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)",

author = "N. Lawrence and A. Martin and G. Toner and M. Stockler and L. Buizen and D. Thomson and V. Gebski and M. Friedlander and A. Yeung and N. Wong and H. Gurney and M. Rosenthal and N. Singhal and G. Kichenadasse and S. Wong and C. Lewis and P. Vasey and P. Grimison",

year = "2016",

month = dec,

day = "1",

doi = "10.1093/annonc/mdw313",

language = "English",

volume = "27",

pages = "2302--2303",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "OXFORD UNIV PRESS INC",

number = "12",

}

Lawrence, N, Martin, A, Toner, G, Stockler, M, Buizen, L, Thomson, D, Gebski, V, Friedlander, M, Yeung, A, Wong, N, Gurney, H, Rosenthal, M, Singhal, N, Kichenadasse, G, Wong, S, Lewis, C, Vasey, P & Grimison, P 2016, 'Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 27, no. 12, pp. 2302-2303. https://doi.org/10.1093/annonc/mdw313

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours : updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). / Lawrence, N.; Martin, A.; Toner, G.; Stockler, M.; Buizen, L.; Thomson, D.; Gebski, V.; Friedlander, M.; Yeung, A.; Wong, N.; Gurney, H.; Rosenthal, M.; Singhal, N.; Kichenadasse, G.; Wong, S.; Lewis, C.; Vasey, P.; Grimison, P.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 27, No. 12, 01.12.2016, p. 2302-2303.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours

T2 - updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

AU - Lawrence, N.

AU - Martin, A.

AU - Toner, G.

AU - Stockler, M.

AU - Buizen, L.

AU - Thomson, D.

AU - Gebski, V.

AU - Friedlander, M.

AU - Yeung, A.

AU - Wong, N.

AU - Gurney, H.

AU - Rosenthal, M.

AU - Singhal, N.

AU - Kichenadasse, G.

AU - Wong, S.

AU - Lewis, C.

AU - Vasey, P.

AU - Grimison, P.

PY - 2016/12/1

Y1 - 2016/12/1

UR - http://www.scopus.com/inward/record.url?scp=85040925777&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdw313

DO - 10.1093/annonc/mdw313

M3 - Letter

C2 - 27502724

AN - SCOPUS:85040925777

VL - 27

SP - 2302

EP - 2303

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 12

ER -

Lawrence N, Martin A, Toner G, Stockler M, Buizen L, Thomson D et al. Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Annals of oncology : official journal of the European Society for Medical Oncology. 2016 Dec 1;27(12):2302-2303. https://doi.org/10.1093/annonc/mdw313